Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Eva Bjerre Ostenfeld"'
Publikováno v:
Andersen, M B, Ovesen, P G, Daugaard, M, Ostenfeld, E B & Fuglsang, J 2020, ' Cycling reduces blood glucose excursions after an oral glucose tolerance test in pregnant women : A randomized crossover trial ', Applied Physiology, Nutrition and Metabolism, vol. 45, no. 11, pp. 1247-1252 . https://doi.org/10.1139/apnm-2020-0020
The aim of this study was to evaluate the effect of an acute bout of cycling immediately after oral glucose intake on glucose metabolism in pregnant women at risk for gestational diabetes mellitus (GDM). Fifteen pregnant women with BMI ≥ 27 kg/m2 w
Autor:
Eva Bjerre Ostenfeld, Per Ovesen, Jens Fuglsang, Charlotte Wolff Poulsen, Mette Bisgaard Andersen, Merete Daugaard
Publikováno v:
Andersen, M B, Fuglsang, J, Ostenfeld, E B, Poulsen, C W, Daugaard, M & Ovesen, P G 2021, ' Postprandial interval walking-effect on blood glucose in pregnant women with gestational diabetes ', American Journal of Obstetrics & Gynecology MFM, vol. 3, no. 6, 100440 . https://doi.org/10.1016/j.ajogmf.2021.100440
BACKGROUND: During pregnancy, postprandial hyperglycemia may increase the risk of complications such as fetal macrosomia. However, evidence on beneficial effects of physical activity on postprandial hyperglycemia is sparse. OBJECTIVE: This study aime
Autor:
Mette Bisgaard Andersen, Eva Bjerre Ostenfeld, Merete Daugaard, Per Ovesen, Jens Fuglsang, Magnus Møller
Publikováno v:
Bisgaard, M S, Ostenfeld, E B, Fuglsang, J, Møller, M, Daugaard, M & Ovesen, P G 2020, ' Maternal prepregnancy body mass index and physical activity during pregnancy assessed by accelerometer ', American Journal of Obstetrics and Gynecology, vol. 2, no. 4, 100182 . https://doi.org/10.1016/j.ajogmf.2020.100182
Maternal prepregnancy overweight and obesity increase the risk of adverse pregnancy outcomes, whereas physical activity during pregnancy has a beneficial effect on both the mother and the fetus. Limited data are available on how maternal prepregnancy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9e33b746542a62ff9d3b19ebaa79a55
https://pure.au.dk/portal/da/publications/maternal-prepregnancy-body-mass-index-and-physical-activity-during-pregnancy-assessed-by-accelerometer(9a03c3ee-5d5c-4561-8535-40a41e1f579c).html
https://pure.au.dk/portal/da/publications/maternal-prepregnancy-body-mass-index-and-physical-activity-during-pregnancy-assessed-by-accelerometer(9a03c3ee-5d5c-4561-8535-40a41e1f579c).html
Autor:
Holger Jon Møller, Eva Bjerre Ostenfeld, Timothy L. Lash, Rune Erichsen, Mogens Tornby Stender, Anders H. Riis, Carsten S. Højskov, Ole Thorlacius-Ussing
Publikováno v:
Riis, A H, Erichsen, R, Ostenfeld, E B, Højskov, C S, Thorlacius-Ussing, O, Stender, M T, Lash, T L & Møller, H J 2019, ' Validating registry data on statins prescriptions by blood measurements ', Pharmacoepidemiology and Drug Safety, vol. 28, no. 5, pp. 609-615 . https://doi.org/10.1002/pds.4700
PURPOSE: To validate prescription registry data as a measurement of adherence to statins through a direct method using assays for selected statins in serial blood samples collected from two prospective cohorts of Danish colorectal cancer patients.MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf14c38f1a8a8239589020d9a6e18e5f
https://pure.au.dk/portal/da/publications/validating-registry-data-on-statins-prescriptions-by-blood-measurements(cf84d0bf-b2d1-4efd-b94b-e4380569f97c).html
https://pure.au.dk/portal/da/publications/validating-registry-data-on-statins-prescriptions-by-blood-measurements(cf84d0bf-b2d1-4efd-b94b-e4380569f97c).html
Autor:
Ole Thorlacius-Ussing, Rune Erichsen, Mogens Vyberg, Eva Bjerre Ostenfeld, Thomas P. Ahern, Anders H. Riis, Timothy L. Lash
Publikováno v:
Lash, T L, Riis, A H, Ostenfeld, E B, Erichsen, R, Vyberg, M, Ahern, T P & Thorlacius-Ussing, O 2017, ' Associations of Statin Use With Colorectal Cancer Recurrence and Mortality in a Danish Cohort ', American Journal of Epidemiology, vol. 186, no. 6, pp. 679-687 . https://doi.org/10.1093/aje/kww245
Lash, T, Hammerich Riis, A, Ostenfeld, E B, Erichsen, R, Vyberg, M, Ahern, T & Thorlacius-Ussing, O 2017, ' Associations of Statin Use With Colorectal Cancer Recurrence and Mortality in a Danish Cohort ', American Journal of Epidemiology, vol. 186, no. 6, pp. 679–687 . https://doi.org/10.1093/aje/kww245
Lash, T, Hammerich Riis, A, Ostenfeld, E B, Erichsen, R, Vyberg, M, Ahern, T & Thorlacius-Ussing, O 2017, ' Associations of Statin Use With Colorectal Cancer Recurrence and Mortality in a Danish Cohort ', American Journal of Epidemiology, vol. 186, no. 6, pp. 679–687 . https://doi.org/10.1093/aje/kww245
In earlier studies of the influence of hydroxymethylglutaryl-coenzyme A reductase inhibitors (also known as statins) on colorectal cancer prognosis, investigators reported a reduced rate of cancer-specific mortality. Studies of recurrence are few and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfde9ecaf29ecf4bf8c8e56dc1b7b70e
https://vbn.aau.dk/da/publications/f771f00a-1672-48a1-84fb-b242a743bd05
https://vbn.aau.dk/da/publications/f771f00a-1672-48a1-84fb-b242a743bd05
Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study
Autor:
Ole Thorlacius-Ussing, Timothy L. Lash, Rune Erichsen, Anders H. Riis, Veronika Fedirko, Eva Bjerre Ostenfeld, Mogens Vyberg, Ashley C. Holmes
Publikováno v:
Holmes, A C, Hammerich Riis, A, Erichsen, R, Fedirko, V, Ostenfeld, E B, Vyberg, M, Thorlacius-Ussing, O & Lash, T 2017, ' Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study ', Acta Oncologica, vol. 56, no. 8, pp. 1111-1119 . https://doi.org/10.1080/0284186X.2017.1304650
Holmes, A C, Riis, A H, Erichsen, R, Fedirko, V, Ostenfeld, E B, Vyberg, M, Thorlacius-Ussing, O & Lash, T L 2017, ' Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study ', Acta Oncologica, vol. 56, no. 8, pp. 1111-1119 . https://doi.org/10.1080/0284186X.2017.1304650
Holmes, A C, Riis, A H, Erichsen, R, Fedirko, V, Ostenfeld, E B, Vyberg, M, Thorlacius-Ussing, O & Lash, T L 2017, ' Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study ', Acta Oncologica, vol. 56, no. 8, pp. 1111-1119 . https://doi.org/10.1080/0284186X.2017.1304650
BACKGROUND: Recurrence is a common outcome among patients that have undergone an intended curative resection for colorectal cancer. However, data on factors that influence colorectal cancer recurrence are sparse. We report descriptive characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::147c50fafc0b8055d554c08f00263005
https://pure.au.dk/portal/da/publications/descriptive-characteristics-of-colon-and-rectal-cancer-recurrence-in-a-danish-populationbased-study(de725e5d-0de2-455b-b085-c8832bd4ab9c).html
https://pure.au.dk/portal/da/publications/descriptive-characteristics-of-colon-and-rectal-cancer-recurrence-in-a-danish-populationbased-study(de725e5d-0de2-455b-b085-c8832bd4ab9c).html
Autor:
Anders H. Riis, Mogens Vyberg, Eva Bjerre Ostenfeld, Ole Thorlacius-Ussing, Timothy L. Lash, Rune Erichsen
Publikováno v:
International Journal of Cancer. 136:2210-2215
Colorectal cancer recurrences are difficult to ascertain accurately and efficiently. We developed and validated an algorithm to identify recurrences that uses Danish medical registries. The algorithm uses metastasis and chemotherapy codes in the Dani
Autor:
Lone Sunde, Louise Faaborg, Estrid S. Hansen, Eva Bjerre Ostenfeld, Isa Niemann, Jacob Christian Lindegaard
Publikováno v:
Faaborg, L, Niemann, I, Ostenfeld, E B, Hansen, E S, Sunde, L & Lindegaard, J C 2016, ' A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group ', Acta Oncologica, vol. 55, no. 2, pp. 234-239 . https://doi.org/10.3109/0284186X.2015.1059486
BACKGROUND: Treatment of postmolar gestational trophoblastic neoplasia (GTN) is often stratified according to FIGO score using methotrexate (MTX) for low-risk patients and first-line multi-agent chemotherapy (e.g. EMA-CO) for high-risk patients. In c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83b059cd0b2be3b7e56dc6af7a3c99d0
https://pure.au.dk/portal/da/publications/a-30year-experience-in-using-oral-methotrexate-as-initial-treatment-for-gestational-trophoblastic-neoplasia-regardless-of-risk-group(7aeb8a0a-a6c3-4eb6-a062-8c7d654dd0fb).html
https://pure.au.dk/portal/da/publications/a-30year-experience-in-using-oral-methotrexate-as-initial-treatment-for-gestational-trophoblastic-neoplasia-regardless-of-risk-group(7aeb8a0a-a6c3-4eb6-a062-8c7d654dd0fb).html
Autor:
Lene Hjerrild Iversen, Rune Erichsen, Mette Nørgaard, Eva Bjerre Ostenfeld, Jacob Jacobsen, Per Gandrup
Publikováno v:
Clinical Epidemiology
Scopus-Elsevier
Ostenfeld, E B, Erichsen, R, Iversen, L H, Gandrup, P, Nørgaard, M & Jacobsen, J 2011, ' Survival of patients with colon and rectal cancer in central and northern Denmark, 1998-2009 ', Clinical Epidemiology, vol. 3 Suppl 1, pp. 27-34 . https://doi.org/10.2147/CLEP.S20617
Scopus-Elsevier
Ostenfeld, E B, Erichsen, R, Iversen, L H, Gandrup, P, Nørgaard, M & Jacobsen, J 2011, ' Survival of patients with colon and rectal cancer in central and northern Denmark, 1998-2009 ', Clinical Epidemiology, vol. 3 Suppl 1, pp. 27-34 . https://doi.org/10.2147/CLEP.S20617
Eva B Ostenfeld1, Rune Erichsen1, Lene H Iversen1,2, Per Gandrup3, Mette Nørgaard1, Jacob Jacobsen11Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Surgery P, Aarhus University Hospital, Aarhus, Denma
Autor:
Ole Thorlacius-Ussing, Lene Hjerrild Iversen, Henrik Toft Sørensen, Anders H. Riis, John A. Baron, Eva Bjerre Ostenfeld, Rune Erichsen
Publikováno v:
Ostenfeld, E B, Erichsen, R, Baron, J A, Thorlacius-Ussing, O, Iversen, L H, Riis, A H, Sørensen, H T & Danish Colorectal Cancer Group 2015, ' Preadmission glucocorticoid use and anastomotic leakage after colon and rectal cancer resections : a Danish cohort study ', BMJ Open, vol. 5, no. 9, e008045 . https://doi.org/10.1136/bmjopen-2015-008045
Ostenfeld, E B, Erichsen, R, Baron, J A, Thorlacius-Ussing, O, Iversen, L H, Riis, A H, Sørensen, H T & Danish Colorectal Cancer Group 2015, ' Preadmission glucocorticoid use and anastomotic leakage after colon and rectal cancer resections : a Danish cohort study ', BMJ Open, vol. 5, no. 9, pp. e008045 . https://doi.org/10.1136/bmjopen-2015-008045
BMJ Open
Ostenfeld, E B, Erichsen, R, Baron, J A, Thorlacius-Ussing, O, Iversen, L H, Riis, A H, Sørensen, H T & Danish Colorectal Cancer Group 2015, ' Preadmission glucocorticoid use and anastomotic leakage after colon and rectal cancer resections : a Danish cohort study ', BMJ Open, vol. 5, no. 9, pp. e008045 . https://doi.org/10.1136/bmjopen-2015-008045
BMJ Open
OBJECTIVE: To examine whether preadmission glucocorticoid use increases the risk of anastomotic leakage after colon and rectal cancer resections.DESIGN: A population-based cohort study.SETTING: Denmark (2001-2011).PARTICIPANTS: We identified patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b20b540523c39a8438d9c626a4d2b75
https://vbn.aau.dk/da/publications/7add682d-0cbe-4106-8123-21fd38f0ace6
https://vbn.aau.dk/da/publications/7add682d-0cbe-4106-8123-21fd38f0ace6